id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-N-0319-0004,FDA,FDA-2003-N-0319,"Agency Information Collection, Activities; Submission for Office of Management and Budget Review; Comment Request; Study to Measure the Compliance of Prescribers With the Contraindication of the Use of Triptans in Migraine Headache Patients With Vascular Disease",Notice,30 Day Proposed Information Collection,2005-11-10T05:00:00Z,2005,11,2005-11-02T05:00:00Z,2005-12-03T04:59:59Z,2025-06-17T17:03:30Z,05-21807,0,0,09000064804956b9